: Introduces a unified section detailing conditions like gastrointestinal lymphomas and gastrointestinal stromal tumors (GIST). Structural Breakdown: The 12-Part Framework
: A new chapter on Enterocolitis and Hepatitis induced by cancer immunotherapy, reflecting the rise of biological treatments in oncology. Microbiota and Probiotics
What sets the 12th edition apart is the introduction of a new senior editorial team that ushers in a fresh era for the text. While the book has always been a collaborative effort, this edition is now guided by a new generation of leaders: s gastrointestinal and liver disease 12th edition
has remained the definitive reference for gastroenterology and hepatology professionals. The upcoming 12th Edition , scheduled for release in December 2025
The book is organized into multiple parts, starting with the "Biology of the Gastrointestinal Tract," which covers topics like Cellular Growth and Neoplasia, Mucosal Immunology, and The Enteric Microbiota, before moving into "Nutrition in Gastroenterology," "Symptoms and Signs," and beyond. The consistent, templated format used throughout the text enables quick retrieval of information. : Introduces a unified section detailing conditions like
For over fifty years, one textbook has stood above all others as the definitive source for clinical gastroenterology and hepatology. The release of , continues this legacy, providing a comprehensive, evidence-based foundation for clinicians, fellows, and residents worldwide.
(published December 2025) remains the gold-standard reference for gastroenterology and hepatology. Led by a new senior editorial team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox, this two-volume set integrates basic science with the latest clinical technologies and treatments. Core Themes and New Chapters While the book has always been a collaborative
: Guided by a new senior team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Decision-Making Tools : Includes over 1,100 full-color illustrations